This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Ensure all technologies interoperate seamlessly to maximize benefits and minimize noise, enabling the security team to focus on genuine alerts. These technologies also reduce the burden on the stretched security resources in healthcare organizations, freeing up IT personnel to focus on other important tasks in their organizations.
ZeOmega integrated its Jiva SDOH Social Care solution with Microsoft Cloud for Healthcare. Health Plan Alliance selected 1upHealth as its preferred health data interoperability vendor. H1 launched an iOS mobile app to better provide clinical insights to lifescience professionals. Disease detection company Viz.ai
The use of public generative AI (GenAI) will take longer to enter the space due to the risk of leaked intellectual property, which is critical in lifesciences, however, as private GPT becomes possible use of GPT will increase. As these trends increase, there will be an expansion of investment in predictive and preventative analytics.
Though it may be too early to expect any form of regulation this year regarding AI from governing bodies in lifesciences, we all know it is coming. Increasingly, lifescience organizations are turning toward automation for their regulatory processes, but the industry will not be fully reliant on automated processes in the coming year.
The ultimate goal for trials is to enhance the quality and efficiency of the study, ensuring the successful delivery of life-saving therapeutics. As sponsors adopt new tools, they will increasingly seek strategies that enable a harmonized, interoperable ecosystem.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content